WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, June 16, 2004, 24(24):5549-5559; doi:10.1523/JNEUROSCI.2719-03.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morinville, A.
Right arrow Articles by Beaudet, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morinville, A.
Right arrow Articles by Beaudet, A.

 Previous Article  |  Next Article 

Cellular/Molecular
Morphine-Induced Changes in {delta} Opioid Receptor Trafficking Are Linked to Somatosensory Processing in the Rat Spinal Cord

Anne Morinville,1,2 Catherine M. Cahill,1 Haneen Aibak,1 Vladimir V. Rymar,1 Amynah Pradhan,2 Cyrla Hoffert,3 Françoise Mennicken,3 Thomas Stroh,2 Abbas F. Sadikot,1 Dajan O'Donnell,3 Paul B. S. Clarke,2 Brian Collier,2 James L. Henry,4 Jean-Pierre Vincent,5 and Alain Beaudet1

1Montreal Neurological Institute, McGill University, Montreal, Québec, Canada H3A 2B4, 2Department of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada H3G 1Y6, 3Department of Molecular Sciences, AstraZeneca R&D Montreal, Montreal, Québec, Canada H4S 1Z9, 4Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada N6A 5C1, and 5Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Université de Nice, 06560 Valbonne, France

An in vivo fluorescent deltorphin (Fluo-DLT) internalization assay was used to assess the distribution and regulation of pharmacologically available {delta} opioid receptors ({delta}ORs) in the rat lumbar (L4-5) spinal cord. Under basal conditions, intrathecal injection of Fluo-DLT resulted in the labeling of numerous {delta}OR-internalizing neurons throughout dorsal and ventral horns. The distribution and number of Fluo-DLT-labeled perikaryal profiles were consistent with that of {delta}OR-expressing neurons, as revealed by in situ hybridization and immunohistochemistry, suggesting that a large proportion of these cells was responsive to intrathecally administered {delta}OR agonists. Pretreatment of rats with morphine for 48 hr resulted in a selective increase in Fluo-DLT-labeled perikaryal profiles within the dorsal horn. These changes were not accompanied by corresponding augmentations in either {delta}OR mRNA or 125I-deltorphin-II binding levels, suggesting that they were attributable to higher densities of cell surface {delta}OR available for internalization rather than to enhanced production of the receptor. Unilateral dorsal rhizotomy also resulted in increased Fluo-DLT internalization in the ipsilateral dorsal horn when compared with the side contralateral to the deafferentation or to non-deafferented controls, suggesting that {delta}OR trafficking in dorsal horn neurons may be regulated by afferent inputs. Furthermore, morphine treatment no longer increased Fluo-DLT internalization on either side of the spinal cord after unilateral dorsal rhizotomy, indicating that µOR-induced changes in the cell surface availability of {delta}OR depend on the integrity of primary afferent inputs. Together, these results suggest that regulation of {delta}OR responsiveness through µOR activation in this region is linked to somatosensory information processing.

Key words: opiate; morphine; internalization; fluorescence microscopy; targeting; narcotic; intrathecal; dorsal rhizotomy


Received May 29, 2003; revised April 22, 2004; accepted April 26, 2004.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
B. Bie, W. Zhu, and Z. Z. Pan
Rewarding Morphine-Induced Synaptic Function of {delta}-Opioid Receptors on Central Glutamate Synapses
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 290 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W.-Y. Xie, Y. He, Y.-R. Yang, Y.-F. Li, K. Kang, B.-M. Xing, and Y. Wang
Disruption of Cdk5-Associated Phosphorylation of Residue Threonine-161 of the {delta}-Opioid Receptor: Impaired Receptor Function and Attenuated Morphine Antinociceptive Tolerance
J. Neurosci., March 18, 2009; 29(11): 3551 - 3564.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Gendron, A. L. Lucido, F. Mennicken, D. O'Donnell, J.-P. Vincent, T. Stroh, and A. Beaudet
Morphine and Pain-Related Stimuli Enhance Cell Surface Availability of Somatic {delta}-Opioid Receptors in Rat Dorsal Root Ganglia
J. Neurosci., January 18, 2006; 26(3): 953 - 962.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-